| Analysis of five HMG‐CoA reductase inhibitors—atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and … MK Pasha, S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, ... Biomedical Chromatography 20 (3), 282-293, 2006 | 152 | 2006 |
| Mitochondrial toxicity of diclofenac and its metabolites via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria: Possible role in drug induced … M Syed, C Skonberg, SH Hansen Toxicology in vitro 31, 93-102, 2016 | 86 | 2016 |
| Design and optimization of quinazoline derivatives as melanin concentrating hormone receptor 1 (MCHR1) antagonists S Sasmal, G Balaji, HRK Reddy, D Balasubrahmanyam, G Srinivas, ... Bioorganic & medicinal chemistry letters 22 (9), 3157-3162, 2012 | 77 | 2012 |
| Concurrent determination of ezetimibe and its phase-I and II metabolites by HPLC with UV detection: quantitative application to various in vitro metabolic stability studies and … SJS Basha, SA Naveed, NK Tiwari, D Shashikumar, S Muzeeb, TR Kumar, ... Journal of Chromatography B 853 (1-2), 88-96, 2007 | 61 | 2007 |
| Effect of some organic solvents on oxidative phosphorylation in rat liver mitochondria: Choice of organic solvents M Syed, C Skonberg, SH Hansen Toxicology in Vitro 27 (8), 2135-2141, 2013 | 33 | 2013 |
| Clinical drug–drug pharmacokinetic interaction potential of sucralfate with other drugs: review and perspectives SP Sulochana, M Syed, DV Chandrasekar, R Mullangi, NR Srinivas European journal of drug metabolism and pharmacokinetics 41, 469-503, 2016 | 23 | 2016 |
| A comprehensive review of the published assays for the quantitation of the immunosuppressant drug mycophenolic acid and its glucuronidated metabolites in biological fluids M Syed, NR Srinivas Biomedical Chromatography 30 (5), 721-748, 2016 | 23 | 2016 |
| ‘Open access’ generic method for continuous determination of major human CYP450 probe substrates/metabolites and its application in drug metabolism studies MNVS Rao, B Biju, AK Ansar, S Mujeeb, M Ramesh, NR Srinivas Xenobiotica 33 (12), 1233-1245, 2003 | 23 | 2003 |
| Discovery of novel, orally available benzimidazoles as melanin concentrating hormone receptor 1 (MCHR1) antagonists PK Sasmal, S Sasmal, PT Rao, B Venkatesham, M Roshaiah, C Abbineni, ... Bioorganic & medicinal chemistry letters 20 (18), 5443-5448, 2010 | 21 | 2010 |
| Mitochondrial toxicity of selective COX-2 inhibitors via inhibition of oxidative phosphorylation (ATP synthesis) in rat liver mitochondria M Syed, C Skonberg, SH Hansen Toxicology in Vitro 32, 26-40, 2016 | 19 | 2016 |
| Applicability of a single time point strategy for the prediction of area under the concentration curve of linezolid in patients: superiority of C trough-over C max-derived … NR Srinivas, M Syed Drugs in R&D 16, 69-79, 2016 | 19 | 2016 |
| Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on … S Muzeeb, P Venkatesh, R Mullangi, NR Srinivas Xenobiotica 36 (9), 838-856, 2006 | 13 | 2006 |
| Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats S Muzeeb, MK Pasha, SJS Basha, R Mullangi, NR Srinivas Xenobiotica 35 (8), 825-838, 2005 | 13 | 2005 |
| Inhibition of ATP synthesis by fenbufen and its conjugated metabolites in rat liver mitochondria M Syed, C Skonberg, SH Hansen Toxicology in Vitro 31, 23-29, 2016 | 10 | 2016 |
| Review of the bioanalytical methods for the determination of methotrexate and its metabolites in in vitro, preclinical and clinical studies: Case studies and … H Patel, P Giri, A Ghoghari, P Delvadia, M Syed, NR Srinivas Biomedical Chromatography 31 (1), e3849, 2017 | 7 | 2017 |
| Species difference in the in vitro and in vivo metabolism of amtolmetin guacil KK Hotha, VB Dasari, AN Shaik, M Syed, V Shivva, RK Lakshmanarao, ... Arzneimittelforschung 60 (11), 667-674, 2010 | 6 | 2010 |
| Glucuronidation of DRF-6574, hydroxy metabolite of DRF-4367 (a novel COX-2 inhibitor) by pooled human liver, intestinal microsomes and recombinant human UDP … S Muzeeb, SJS Basha, D Shashikumar, R Mullangi, NR Srinivas European journal of drug metabolism and pharmacokinetics 31, 299-309, 2006 | 5 | 2006 |
| Pre-clinical assessment of DRF 4367, a novel COX-2 inhibitor: Evaluation of pharmacokinetics, absolute oral bioavailability and metabolism in mice and comparative inter-species … R Bhamidipati, S Mujeeb, PV Dravid, AA Khan, SK Singh, YK Rao, ... Xenobiotica 35 (3), 253-271, 2005 | 5 | 2005 |
| Intranasal Pharmacokinetic Data for Triptans Such as Sumatriptan and Zolmitriptan Can Render Area Under the Curve (AUC) Predictions for the Oral Route: Strategy Development and … NR Srinivas, M Syed Journal of Pain & Palliative Care Pharmacotherapy 30 (1), 13-24, 2016 | 4 | 2016 |
| Area under the curve predictions of dalbavancin, a new lipoglycopeptide agent, using the end of intravenous infusion concentration data point by regression analyses such as … RK Bhamidipati, M Syed, R Mullangi, N Srinivas Xenobiotica 48 (2), 148-156, 2018 | 3 | 2018 |
Mohammed Khalid PashaLee Kong Chian School of Medicine- Imperial college London-NTUVerified email at ntu.edu.sg
